{"id":"qishenyiqi-dripping-pills","safety":{"commonSideEffects":[{"rate":null,"effect":"Gastrointestinal upset"},{"rate":null,"effect":"Allergic reactions"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"This herbal combination works by invigorating qi (vital energy) and blood flow, reducing blood stasis, and strengthening myocardial contractility. It is used in traditional Chinese medicine to address deficiency patterns and circulatory dysfunction associated with cardiovascular conditions.","oneSentence":"Qishenyiqi dripping pills is a traditional Chinese medicine formulation that enhances cardiac function and improves blood circulation to support heart health.","_ai_confidence":"low"},"_scrapedAt":"2026-03-27T23:36:51.945Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Angina pectoris"},{"name":"Heart failure"},{"name":"Myocardial infarction recovery"}]},"trialDetails":[{"nctId":"NCT07041359","phase":"PHASE4","title":"Pre-trial of Clinical Trial of Traditional Chinese Medicine Treatment for Elderly Patients With Coronary Heart Disease Who Are Still Symptomatic After Optimal Medical Treatment","status":"RECRUITING","sponsor":"China National Center for Cardiovascular Diseases","startDate":"2025-08-18","conditions":"Coronary Arterial Disease (CAD)","enrollment":120},{"nctId":"NCT04983043","phase":"PHASE2","title":"Efficacy and Safety of QiShen YiQi Dripping Pills in Chronic Heart Failure","status":"COMPLETED","sponsor":"Tasly Pharmaceutical Group Co., Ltd","startDate":"2021-06-10","conditions":"Chronic Heart Failure With Reduced Ejection Fraction","enrollment":228},{"nctId":"NCT04944706","phase":"PHASE2","title":"Efficacy and Safety of Qishenyiqi Dripping Pills for Treating Chronic Heart Failure With Preserved Ejection Fraction","status":"COMPLETED","sponsor":"Tasly Pharmaceutical Group Co., Ltd","startDate":"2021-07-27","conditions":"Chronic Heart Failure With Preserved Ejection Fraction","enrollment":225},{"nctId":"NCT06699420","phase":"PHASE4","title":"Qishenyiqi Dripping Pill for Coronary Microvascular Disease","status":"RECRUITING","sponsor":"Qilu Hospital of Shandong University","startDate":"2023-11-08","conditions":"Coronary Microvascular Disease","enrollment":162},{"nctId":"NCT06699407","phase":"PHASE4","title":"Qishenyiqi for Ventricular Remodeling After Myocardial Infarction","status":"NOT_YET_RECRUITING","sponsor":"Qilu Hospital of Shandong University","startDate":"2024-11-20","conditions":"Chronic Stable Heart Failure","enrollment":210},{"nctId":"NCT06006689","phase":"PHASE2","title":"Efficacy and Safety of QiShen YiQi Dripping Pills in the Treatment of Diabetic Kidney Disease (Syndrome of Qi Deficiency With Blood Stasis)","status":"RECRUITING","sponsor":"Tasly Pharmaceutical Group Co., Ltd","startDate":"2023-09-04","conditions":"Diabetic Kidney Disease","enrollment":228},{"nctId":"NCT04471298","phase":"PHASE1","title":"A Study of Qishenyiqi Dripping Pills in Healthy Participants","status":"COMPLETED","sponsor":"Tasly Pharmaceutical Group Co., Ltd","startDate":"2020-09-21","conditions":"Healthy Participants","enrollment":36},{"nctId":"NCT02875639","phase":"PHASE2","title":"A Clinical Research of Qi Deficiency and Blood Stasis Syndrome (Different Disease With Syndrome)","status":"UNKNOWN","sponsor":"Zhu Mingjun","startDate":"2016-06","conditions":"Ischemic Heart Failure","enrollment":180},{"nctId":"NCT01555320","phase":"NA","title":"Clinical Assessment of Complementary Treatment With Qishen Yiqi Dripping Pills on Ischemic Heart Failure","status":"UNKNOWN","sponsor":"State Administration of Traditional Chinese Medicine of the People's Republic of China","startDate":"2012-03","conditions":"Ischemic Heart Failure","enrollment":640}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":10,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Qishenyiqi dripping pills","genericName":"Qishenyiqi dripping pills","companyName":"Qilu Hospital of Shandong University","companyId":"qilu-hospital-of-shandong-university","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Qishenyiqi dripping pills is a traditional Chinese medicine formulation that enhances cardiac function and improves blood circulation to support heart health. Used for Angina pectoris, Heart failure, Myocardial infarction recovery.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}